Whole Genome Sequencing has identified certain polymorphisms affecting genes encoding triggering receptors expressed on myeloid cells (TREMs) with increased risk of non-familial (sporadic) Alzheimer's disease. TREM signaling is known to be important in the innate immune response, particularly in the inflammatory response. However, the relationship between the function of TREM receptors and Alzheimer's disease pathology is largely unresolved. This project will investigate the relevant polymorphisms to determine how they facilitate Alzheimer's disease and how they might be targeted to improve brain immune function.
The Biological Impact of TREM Locus Mutations in Alzheimer’s Disease
2015 to 2016
Funding to date:
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.